{"id":341124,"date":"2019-03-12T05:35:03","date_gmt":"2019-03-12T05:35:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=341124"},"modified":"2019-03-12T05:35:03","modified_gmt":"2019-03-12T05:35:03","slug":"global-oral-vaccines-market-2019-global-production-growth-share-demand-and-applications-market-research-report-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-oral-vaccines-market-2019-global-production-growth-share-demand-and-applications-market-research-report-to-2025_341124.html","title":{"rendered":"Global Oral Vaccines Market 2019 Global Production, Growth, Share, Demand and Applications Market Research Report to 2025"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Oral Vaccines Market”<\/div>\n<\/div>\n<\/div>\n
WiseGuyRerports.com Presents \u201cGlobal Oral Vaccines Market Insights, Forecast to 2025\u201d New Document to its Studies Database<\/div>\n

 <\/p>\n

Oral vaccines<\/a><\/strong> are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality. 
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality. 
In the last several years, global market of oral vaccines developed rapidly, with an average growth rate of 6.31%. In 2017, global revenue of oral vaccines is nearly 2.01 billion USD; the actual consumption is about 2.2 billion doses. 
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine in 2017 is about 94%, and the proportion is in decreasing trend from 2012 to 2017. 
The global Oral Vaccines market is valued at 2010 million US$ in 2018 and will reach 3480 million US$ by the end of 2025, growing at a CAGR of 7.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Vaccines market based on company, product type, end user and key regions.<\/p>\n

This report studies the global market size of Oral Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Vaccines in these regions. 
This research report categorizes the global Oral Vaccines market by top players\/brands, region, type and end user. This report also studies the global Oral Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.<\/p>\n

The following manufacturers are covered in this report, with sales, revenue, market share for each company: 
Merck 
GSK 
Sanofi 
Lanzhou Institute 
Serum Institute 
Valneva 
Shanghai United Cell 
Bibcol 
PaxVax 
Vabiotech 
Tiantan Biological 
EuBiologics 
Panacea Biotec Ltd 
Bio-Med 
Halfkin Bio-Pharmaceuticals<\/strong><\/p>\n

 <\/strong><\/p>\n

 Request Free Sample Report<\/strong> @ https:\/\/www.wiseguyreports.com\/sample-request\/3803617-global-oral-vaccines-market-insights-forecast-to-2025<\/a>                                 <\/p>\n

                                     <\/p>\n

Market size by Product 
<\/strong>Rotavirus Vaccine 
Cholera Vaccine 
Oral Polio Vaccine 
Others 
Market size by End User 
<\/strong>Public 
Private<\/p>\n

Market size by Region 
<\/strong>North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan <\/p>\n

The study objectives of this report are: 
<\/strong>To study and analyze the global Oral Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. 
To understand the structure of Oral Vaccines market by identifying its various subsegments. 
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). 
Focuses on the key global Oral Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. 
To project the value and sales volume of Oral Vaccines submarkets, with respect to key regions. 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.<\/p>\n

 <\/strong><\/p>\n

Complete Report Details @ <\/strong>https:\/\/www.wiseguyreports.com\/reports\/3803617-global-oral-vaccines-market-insights-forecast-to-2025<\/a>                       <\/p>\n

 <\/p>\n

Table Of Contents:      <\/strong><\/p>\n

1 Study Coverage 
1.1 Oral Vaccines Product 
1.2 Market Segments 
1.3 Key Manufacturers Covered 
1.4 Market by Type 
<\/strong>1.4.1 Global Oral Vaccines Market Size Growth Rate by Product 
1.4.2 Rotavirus Vaccine 
1.4.3 Cholera Vaccine 
1.4.4 Oral Polio Vaccine 
1.4.5 Others 
1.5 Market by End User 
<\/strong>1.5.1 Global Oral Vaccines Market Size Growth Rate by End User 
1.5.2 Public 
1.5.3 Private 
1.6 Study Objectives 
1.7 Years Considered<\/strong><\/p>\n

2 Executive Summary 
<\/strong>2.1 Global Oral Vaccines Market Size 
2.1.1 Global Oral Vaccines Revenue 2014-2025 
2.1.2 Global Oral Vaccines Sales 2014-2025 
2.2 Oral Vaccines Growth Rate by Regions 
2.2.1 Global Oral Vaccines Sales by Regions 
2.2.2 Global Oral Vaccines Revenue by Regions<\/p>\n

…..<\/strong><\/p>\n

11 Company Profiles 
11.1 Merck 
<\/strong>11.1.1 Merck Company Details 
11.1.2 Company Business Overview 
11.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2014-2019) 
11.1.4 Merck Oral Vaccines Products Offered 
11.1.5 Merck Recent Development 
11.2 GSK 
<\/strong>11.2.1 GSK Company Details 
11.2.2 Company Business Overview 
11.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2014-2019) 
11.2.4 GSK Oral Vaccines Products Offered 
11.2.5 GSK Recent Development 
11.3 Sanofi 
<\/strong>11.3.1 Sanofi Company Details 
11.3.2 Company Business Overview 
11.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2014-2019) 
11.3.4 Sanofi Oral Vaccines Products Offered 
11.3.5 Sanofi Recent Development 
11.4 Lanzhou Institute 
<\/strong>11.4.1 Lanzhou Institute Company Details 
11.4.2 Company Business Overview 
11.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2014-2019) 
11.4.4 Lanzhou Institute Oral Vaccines Products Offered 
11.4.5 Lanzhou Institute Recent Development 
11.5 Serum Institute 
<\/strong>11.5.1 Serum Institute Company Details 
11.5.2 Company Business Overview 
11.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2014-2019) 
11.5.4 Serum Institute Oral Vaccines Products Offered 
11.5.5 Serum Institute Recent Development <\/p>\n

 Continued…….<\/strong>                                                      <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com<\/a>
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

 <\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Oral Vaccines Market” WiseGuyRerports.com Presents \u201cGlobal Oral Vaccines Market Insights, Forecast to 2025\u201d New Document to its Studies Database   Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-341124","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/341124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=341124"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/341124\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=341124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=341124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=341124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}